As of 2025-07-09, the Relative Valuation of Chromadex Corp (CDXC) is 4.05 USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.87 USD, the upside of Chromadex Corp based on Relative Valuation is -48.6%.
The range of the Relative Valuation is 2.43 - 5.23 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.7x - 47.6x | 41.9x |
| Forward P/E multiples | 20.0x - 41.9x | 28.6x |
| Fair Price | 2.43 - 5.23 | 4.05 |
| Upside | -69.1% - -33.5% | -48.6% |
| Date | P/E |
| 2025-05-09 | 81.39 |
| 2025-05-08 | 84.02 |
| 2025-05-07 | 76.84 |
| 2025-05-06 | 79.39 |
| 2025-05-05 | 76.84 |
| 2025-05-02 | 72.75 |
| 2025-05-01 | 68.75 |
| 2025-04-30 | 71.38 |
| 2025-04-29 | 70.75 |
| 2025-04-28 | 69.29 |
| 2025-04-25 | 67.11 |
| 2025-04-24 | 67.11 |
| 2025-04-23 | 65.38 |
| 2025-04-22 | 62.65 |
| 2025-04-21 | 59.38 |
| 2025-04-17 | 61.47 |
| 2025-04-16 | 59.47 |
| 2025-04-15 | 58.15 |
| 2025-04-14 | 55.83 |
| 2025-04-11 | 53.92 |
| 2025-04-10 | 51.56 |
| 2025-04-09 | 54.93 |
| 2025-04-08 | 49.29 |
| 2025-04-07 | 51.11 |